Literature DB >> 10403602

Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.

K Rave1, R Bender, T Heise, P T Sawicki.   

Abstract

OBJECTIVE: To determine the impact of self-monitoring of blood pressure values (BP(S)) as compared with office blood pressure measurements (BP(O)) on the progression of diabetic nephropathy.
DESIGN: Long-term, follow-up cohort study. SUBJECTS AND METHODS: Hypertensive, type 1 diabetic patients with overt diabetic nephropathy were investigated. Patients initially participated in a hypertension treatment and teaching programme including extensive advice on blood pressure self-monitoring. Self-monitoring and office blood pressure values were continuously assessed during the entire follow-up period. Progression of diabetic nephropathy over the study period was individually assessed as the mean decline of glomerular filtration rate (GFR) per patient per year. Baseline and follow-up parameters were included in stepwise multiple regression analyses with the decline of GFR per year as the dependent variable.
RESULTS: Seventy-seven type 1 diabetic patients (37 women, 40 men) were followed for a mean period of 6.2 +/- 2.8 years (mean +/- SD; range 2-12) resulting in a total of 481 patient-years. During the follow-up period, mean BP(O) decreased from 166/95 at baseline to 154/89 mmHg during follow-up, and mean BP(S) fell from 159/93 to 138/83 mmHg. The mean decline of GFR was 4.1 +/- 5.6 ml/min per year. Loss of kidney function was significantly correlated with proteinuria, blood pressure and glycosylated haemoglobin values. In the multiple regression analyses, BP(S) predicted the loss of renal function better than BP(O) (R2 = 0.52 versus 0.42). The simple correlation between BP(S) and GFR decline was higher compared to BP(O) and GFR (r = -0.42; P < 0.0001 versus -0.33; P < 0.004).
CONCLUSION: Blood pressure self-monitoring values are a better predictor of progression of diabetic nephropathy when compared with office blood pressure measurements.

Entities:  

Mesh:

Year:  1999        PMID: 10403602     DOI: 10.1097/00004872-199917050-00002

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

Review 1.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

Review 2.  The complex relationship between CKD and ambulatory blood pressure patterns.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Adv Chronic Kidney Dis       Date:  2015-03       Impact factor: 3.620

Review 3.  Home blood pressure monitoring: how good a predictor of long-term risk?

Authors:  Samia Sheikh; Arjun D Sinha; Rajiv Agarwal
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

4.  Clinical implications of ambulatory and home blood pressure monitoring.

Authors:  Soon-Gil Kim
Journal:  Korean Circ J       Date:  2010-09-30       Impact factor: 3.243

Review 5.  Management of hypertension in chronic kidney disease.

Authors:  Raymond R Townsend; Sandra J Taler
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

6.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

Review 7.  Practical advice for home blood pressure measurement.

Authors:  Donald W McKay; Marshall Godwin; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

8.  Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nephrosclerosis.

Authors:  Hiroko Suzuki; Kazuyoshi Okada; Masanori Abe; Noriaki Maruyama; Yoshinori Yoshida; Seishiro Baba; Hiroyuki Takashima; Masayoshi Soma
Journal:  Clin Exp Nephrol       Date:  2012-11-09       Impact factor: 2.801

9.  Why is self-monitoring reimbursed for blood glucose but not blood pressure?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738

10.  Predictors of progression in hypertensive renal disease in children.

Authors:  Empar Lurbe; Vicente Alvarez; Josep Redon
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.